Company / Current Assets
Entera Bio Ltd. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$15.3M
FY2025
5-year range
$9.0M / $25.3M
FY2021-FY2025
Trend
+70.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 3 years of decline, reaching $15M.
Based on SEC 10-K filings.
$15M in FY2025 with a 3-year CAGR of +6.0%.
Improved from $11M to $15M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +6.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +6.0%, indicating consistent growth.
- In FY2025, current assets increased 70.5% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.3M | +70.5% |
| FY2024 | $9.0M | -20.3% |
| FY2023 | $11.3M | -12.4% |
| FY2022 | $12.8M | -49.3% |
| FY2021 | $25.3M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026